Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Arthropathy with infiltrate IgG4-positive plasma cells in synovium.
Umekita K, Kaneko Y, Yorita K, Hashiba Y, Matsuda M, Miyauchi S, Ueno S, Takajo I, Kusumoto N, Nagatomo Y, Marutsuka K, Okayama A. Umekita K, et al. Among authors: hashiba y. Rheumatology (Oxford). 2012 Mar;51(3):580-2. doi: 10.1093/rheumatology/ker350. Epub 2011 Nov 24. Rheumatology (Oxford). 2012. PMID: 22120458 No abstract available.
Arteriosclerosis of whole aorta in takayasu arteritis.
Umekita K, Hashiba Y, Kariya-Kaneko Y, Matsuda M, Okayama A. Umekita K, et al. Among authors: hashiba y. J Rheumatol. 2012 Jun;39(6):1291. doi: 10.3899/jrheum.120183. J Rheumatol. 2012. PMID: 22661416 No abstract available.
Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan.
Mori S, Yoshitama T, Hidaka T, Sakai F, Hasegawa M, Hashiba Y, Suematsu E, Tatsukawa H, Mizokami A, Yoshizawa S, Hirakata N, Ueki Y. Mori S, et al. Among authors: hashiba y. PLoS One. 2017 Jun 8;12(6):e0179179. doi: 10.1371/journal.pone.0179179. eCollection 2017. PLoS One. 2017. PMID: 28594905 Free PMC article.
Leukocytapheresis in rheumatoid arthritis.
Hidaka T, Hashiba Y, Kubo K, Kai Y, Maeda K. Hidaka T, et al. Among authors: hashiba y. Transfus Apher Sci. 2017 Oct;56(5):698-702. doi: 10.1016/j.transci.2017.08.017. Epub 2017 Aug 30. Transfus Apher Sci. 2017. PMID: 28918917 Review.
The time-sequential changes of risk factors for adult T-cell leukemia development in human T-cell leukemia virus-positive patients with rheumatoid arthritis: a retrospective cohort study.
Umekita K, Hashiba Y, Kariya Y, Kubo K, Miyauchi S, Aizawa A, Umeki K, Nomura H, Kawaguchi T, Matsuda M, Takajo I, Hidaka T, Okayama A. Umekita K, et al. Among authors: hashiba y. Mod Rheumatol. 2019 Sep;29(5):795-801. doi: 10.1080/14397595.2018.1519890. Epub 2018 Oct 25. Mod Rheumatol. 2019. PMID: 30246572
Human T-cell leukemia virus type 1 may invalidate T-SPOT.TB assay results in rheumatoid arthritis patients: A retrospective case-control observational study.
Umekita K, Hashiba Y, Iwao K, Iwao C, Kimura M, Kariya Y, Kubo K, Miyauchi S, Kudou R, Rikitake Y, Takajo K, Kawaguchi T, Matsuda M, Takajo I, Inoue E, Hidaka T, Okayama A. Umekita K, et al. Among authors: hashiba y. PLoS One. 2020 May 27;15(5):e0233159. doi: 10.1371/journal.pone.0233159. eCollection 2020. PLoS One. 2020. PMID: 32459801 Free PMC article. Clinical Trial.
Effectiveness and safety of non-tumor necrosis factor inhibitor therapy for anti-human T-cell leukemia virus type 1 antibody-positive rheumatoid arthritis.
Endo Y, Fukui S, Umekita K, Suzuki T, Miyamoto J, Morimoto S, Shimizu T, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Origuchi T, Okada A, Fujikawa K, Mizokami A, Matsuoka N, Aramaki T, Ueki Y, Eguchi K, Kariya Y, Hashiba Y, Hidaka T, Okayama A, Kawakami A, Nakamura H. Endo Y, et al. Among authors: hashiba y. Mod Rheumatol. 2021 Sep;31(5):972-978. doi: 10.1080/14397595.2020.1847802. Epub 2020 Nov 27. Mod Rheumatol. 2021. PMID: 33161771
73 results